NEW YORK, Feb. 17, 2026 /PRNewswire/ -- The American Journal of Audiology has peer-reviewed and published the positive outcomes of U.S. tinnitus patients treated with Lenire, the only FDA approved ...
The FDA granted de novo approval to Neuromod Devices' Lenire, a bimodal neuromodulation device that is the first of its kind to be approved to treat tinnitus, the company announced. The device ...
Lenire® is a bimodal neuromodulation device which has been proven to provide long term relief from tinnitus that lasts for at least 12-months after treatment in large scale clinical trials. [1],[3] ...
DUBLIN--(BUSINESS WIRE)--Neuromod Devices Limited (“Neuromod”), the Irish medical device company specialising in the treatment of tinnitus, a chronic condition that affects 10-15% of the global ...
Clinical trial concludes that bimodal neuromodulation combining sound and electrical stimulation of the tongue can significantly reduce tinnitus symptoms, and therapeutic effects can be sustained for ...
When Elliot Gerberg wakes up, he often hears a single tone in his head. The tone — a ceaseless, monotone ringing in his ears that Gerberg finds exhausting — is a sign of tinnitus, a condition without ...
Lenire is now Tinnitus UK's safest and most effective available tinnitus treatment option following a wholesale review of the charity's rating system. Tinnitus UK's new rating acknowledges Lenire's ...
A new clinical trial is to test whether a pocket-sized device that uses sound simulation to reboot faulty ‘wiring’ in the brain could cure people with the debilitating hearing disorder tinnitus. A new ...
81.8% of patients with bothersome tinnitus treated with Lenire at New York Hearing Doctors reported significant improvement in a real-world clinical setting.1,2 Patients with bothersome tinnitus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results